AbCellera Biologics Inc vs Seagate Technology Holdings PLC — how do they compare? AbCellera Biologics Inc trades at $9.23 (market cap $2.99B), while Seagate Technology Holdings PLC trades at $842.99 (market cap $185.97B). The key difference: Seagate Technology Holdings PLC is far larger — about 62.2× AbCellera Biologics Inc's market cap, and Seagate Technology Holdings PLC pays a 0.36% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | STX | |
|---|---|---|
Market Cap | $2.99B | $185.97B |
Sector | Health | Technology |
52-Week High | $9.76 | $1.09K |
52-Week Low | $2.78 | $154.43 |
Enterprise Value | $2.58B | $188.12B |
Dividend Yield | — | 0.36% |
Trailing returns across standard periods
Latest headlines on both assets
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Read more on STX →